Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 201, Supplement 682
The 90th Annual Meeting of The German Physiological Society
3/26/2011-3/29/2011
Regensburg, Germany


L-TYPE CA2+ CHANNELS IN HUMAN DISEASE
Abstract number: SS21

*Striessnig1 J.

Mutations within the genes encoding pore forming a1-subunits of voltage-gated L-type Ca2+ channels (Cav1 channels) give rise to different human diseases thereby providing exciting new insight into functionally relevant structural features of these channels. For example, voltage-sensor mutations in skeletal muscle Cav1.1 channels (CACNA1S) cause Hypokalemic Periodic Paralysis by creating an aberrant ion pore resulting in depolarizing leak currents. Sporadic Cav1.2 (CACNA1C) mutations in IS6 helices cause Timothy Syndrome (a multisystem disorder including long-QT interval and sudden cardiac death) by slowing voltage-and Ca2+-dependent inactivation. Congenital stationary night blindness type 2 results from loss-of function mutations in Cav1.4 (CACNA1F) channels which trigger glutamate release from retinal photoreceptor terminals. A mutation partially truncating the long C-terminal tail revealed an intramolecular protein-protein interaction within the C-terminus that turns off calmodulin-mediated Ca2+-dependent inactivation of Cav1.4 channels to permit the prolonged Ca2+ influx required for photoreceptor signaling. This observation led to the discovery of a similar regulatory mechanism in Cav1.3 channels in which a distal helical domain interacts with a more proximal one within the C-terminal tail. This moderates Ca2+-dependent inactivation of Cav1.3 and shifts the activation voltage-dependence to more positive voltages. The distal domain is absent in short Cav1.3 splice variants, explaining their more negative activation range and faster inactivation. Therefore alternative splicing enables Cav1.3 channels to adjust their biophysical properties to different cellular needs, such as for their known pacemaker function in heart and neurons, including dopaminergic substantia nigra neurons. We have recently discovered a novel human disease (SANDD) resulting from a loss-of-function mutation in the Cav1.3 a1-subunit gene (CACNA1D). Affected individuals suffer from congenital deafness and sinoatrial node dysfunction, emphasizing the important role of these channels for cardiac pacemaking and neurotransmitter release in sensory cells. (Support: FWF P20670, University of Innsbruck; Geers-Stiftung, Bonn; Imhoff-Stiftung, Köln; Köln Fortune, University Hospital of Cologne)

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 201, Supplement 682 :SS21

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE